Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Clinical Lab Tests Measure Heart Disease Risk; Guide Prevention And Treatment

WASHINGTON, March 8, 2013 /PRNewswire-USNewswire/ -- Most of us know about lab tests for high cholesterol and how important they are in helping prevent and control heart disease.  But lab tests do much more—helping physicians prevent heart problems, diagnose heart attacks, and manage heart conditions.

Diagnosing heart attacks

One of the most important roles is helping physicians diagnose heart attacks, even when the symptoms are unclear. Doctors often use a test that measures the enzyme troponin that is released after a myocardial infarction, or heart attack, has occurred.

A troponin test is often the first test that emergency rooms use because the protein appears early, giving physicians a clue to whether a heart attack is occurring.  Troponin stays in the blood for as long as a week, allowing physicians to identify heart attacks and take action to prevent further damage even if the patient was slow to seek medical care.

One study found that testing led to a 50% increase in patients diagnosed with a confirmed heart attack.

"The troponin test can help save lives," said Alan Mertz, President of the American Clinical Laboratory Association (ACLA). "It helps physicians determine whether patients who come to the emergency room with chest pains are really having a heart attack.  If so, patients can get immediate care; if not, they can go home without worry." 

The tests, which cost $25 and $50, may be able to help reduce the $12 billion spent every year on hospitalizing patients who are not actually experiencing heart attacks. 

Doctors also often perform another lab test called myoglobin along with the troponin test to diagnose or rule out a heart attack. Myoglobin is one of the first proteins to be released after a heart attack occurs. 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,335.28 -19.12 -0.12%
NASDAQ 3,496.43 -2.54 -0.07%
S&P 500 1,666.29 -1.18 -0.07%
US 10 Yr 1.965% +0.016

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs